ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)

Array ( [0] => Array ( [value] => Recherche [safe] => Recherche [view] => Recherche ) )
Domaine de recherche :
Santé
Type de financement :
H2020
Type d'instrument :
N / A
Deadline :
Mercredi 18 Avril 2018
Budget indicatif :
entre 4 et 5 millions d'euros par projet
Budget total :
5 millions d'euros
Code de l'appel : SC1-HCO-04-2018
En savoir plus
À noter :

Specific Challenge:

The EU Joint Programming Initiative on Neurodegenerative Diseases Research, in particular Alzheimer's (JPND), was established in 2009 as the pilot of the Member State-led Joint Programming Initiatives and enables the participating EU Member States to work together on the challenge of age-related neurodegenerative diseases. JPND allows the establishment, alignment and building on of national research programmes to increase the effectiveness and impact of research efforts.

Building on earlier successes of the JPND Research Strategy in scaling-up and establishing synergies with Horizon 2020, there is a need to continue previous efforts to consolidate the JPND successes in defragmentation, better coordination and alignment amongst the countries participating in the JPND.

Scope:

Proposals should pool the necessary financial resources from participating national or regional research programmes in the area of neurodegenerative diseases research by implementing a transnational joint call for proposals resulting in grants to third parties with EU co-funding, with a view to scale-up the implementation of the JPND Research Strategy. Proposers are requested to also implement other joint activities, including training and additional joint calls without EU co-funding.

Proposals should also promote the strategic alignment of research activities related to neurodegenerative diseases across Europe, such as developing and aligning national research plans and strategies, making data bases more accessible and interoperable, harmonisation of measurements and methodologies, networking of already existing structures and studies, training etc.

Proposals should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this.

Participation of legal entities from third countries is encouraged in the joint call as well as in other joint activities including additional joint calls without EU co-funding. Participants from these countries may request a Union contribution (on the basis of the ERA-NET unit cost) for the coordination costs of additional activities.

The specific focus of the joint call will be further developed by the beneficiaries of this action.

Expected Impact:

  • Funding of research proposals on a topic identified by the JPND implementation plan or by their action groups, which needs to be addressed at European level and which is complementary to topics of the EC work programmes.
  • Leverage transnational excellent research with EU-added value in the area of neurodegenerative diseases.
  • Increased commitment of participating countries to the implementation of the JPND Strategic Research Agenda.
  • Establishment and alignment of national and regional plans and initiatives on neurodegenerative diseases.
  • Strengthened exchange and better interoperability between existing European infrastructures and data bases.
  • Enhancement and/or better exploitation of national or EC-supported activities.